Human tumor stem cell assay. A prospective clinical trial

Area of Science:

• Oncology
• Cancer Research
• Clinical Trials

Background:

• Advanced malignancies present challenges in selecting effective chemotherapy.
• Personalized medicine approaches are crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate the utility of a human tumor stem cell assay in guiding chemotherapy selection for advanced cancers.
• To assess the assay's predictive accuracy for treatment response.

Main Methods:

• Prospective clinical trial with 53 patients.
• Human tumor stem cell assay using soft agar cultures.
• Assessment of cloning efficiency, contamination rates, and predictive values.

Main Results:

• Cloning efficiency exceeded 90% with minimal contamination (<3%).
• The assay demonstrated a 65% true-positive and 90% true-negative rate in predicting chemotherapy response.
• Preliminary data on predicting response to hyperthermia were also presented.

Conclusions:

• The human tumor stem cell assay is a promising tool for selecting chemotherapeutic agents in advanced malignancies.
• The assay's predictive accuracy supports its role in developing individualized treatment plans.
• Further research may explore its application with other treatment modalities like hyperthermia.